TherapeuticsMD, Inc.
TXMD
TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects includeā¦ read more
Healthcare
Drug ManufacturersāSpecialty & Generic
19 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$2.01
Price0.00%
$0.00
1Y
Price
Market Cap
$23.264m
Small
Price/Earnings 3y Avg5y Avg
102.4x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-15.5%
EBITDA Margin+13.1%
Net Profit Margin+129.3%
Free Cash Flow Margin-15.5%
EBITDA Margin+13.1%
Net Profit Margin+129.3%
Free Cash Flow MarginRevenue
$3.353m
+11.0%
1y CAGR+39.3%
3y CAGR+4.9%
5y CAGREarnings
$179k
+131.5%
1y CAGR+94.7%
3y CAGR+43.7%
5y CAGREPS
$0.02
+140.0%
1y CAGR+96.0%
3y CAGR+95.2%
5y CAGRBook Value
$26.973m
$37.581m
Assets$10.608m
Liabilities$5.831m
DebtDebt to Assets
15.5%
-1.7x
Debt to EBITDAFree Cash Flow
$2.674m
+10.3%
1y CAGR+80.5%
3y CAGR+85.4%
5y CAGRNo items found.
Press Releases
Statements and updates from the company